Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
99 participants
INTERVENTIONAL
2021-04-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
(B): Beidseitige Fronto-Spheno-Ethmoidektomie mit maximaler Erweiterung des Zuganges zur Stirnhöhle (Draf Typ III): Unter einem Draf Typ III verste. (C) Beidseitige Spheno-Ethmoidektomie: Abtragung des Processus uncinatus, die Eröffnung der Kieferhöhle, die Eröffnung des vorderen und hinteren Siebbeinsystems und die Eröffnung der Keilbeinhöhle.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Compare Resection Versus Preservation of the Middle Turbinate in Surgery for Nasal Polyps
NCT02855931
A Study of Different Endoscopic Surgery Procedures in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
NCT03878355
Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps
NCT04104594
Endoscopic Frontal Sinus Surgery Draf III in Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps
NCT05979662
Endoscopic Direct "Draf IIa" (Carolyn's Window Approach) Versus Endoscopic Angled "Draf IIa"Approach in Chronic Rhinosinusitis With Frontal Sinus Affection ( A Comparative Study ).
NCT06668844
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
(B): Beidseitige Fronto-Spheno-Ethmoidektomie mit maximaler Erweiterung des Zuganges zur Stirnhöhle (Draf Typ III): Unter einem Draf Typ III verste. (C) Beidseitige Spheno-Ethmoidektomie: Abtragung des Processus uncinatus, die Eröffnung der Kieferhöhle, die Eröffnung des vorderen und hinteren Siebbeinsystems und die Eröffnung der Keilbeinhöhle.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bilateral Spheno-Ethmoidectomy:
1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
1\) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
Bilateral Fronto-Spheno-Ethmoidectomy + Draf 2b
1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
1\) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
Draf Typ 3
1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
1\) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
1\) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zurich University Hospital
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID 2020-00322
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.